Because increased levels of Aβ cause aggregation, which is responsible for the formation of plaques and the induction of tau pathology, it leads to cell death and neurodegeneration; therefore, Aβ is the primary target for AD [38, 39]. Here, MAPT is linked to Alzheimer disease.